3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow PharmAthene UK Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens) Alhydrogel, rF1 and rV protein antigens - Plague | Phase 1 | Completed | PharmAthene UK Limited | 123 | 2005-10-01 | 2008-09-15 |
| Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed AVA, rPA vaccine containing alhydrogel - Bacillus Anthracis (Anthrax) | Phase 2 | Completed | PharmAthene UK Limited | 226 | 2005-03-01 | 2008-09-15 |
| Phase II Study of Range and Schedule of rPA Doses rPA vaccine containing alhydrogel - Prevention of Bacillus Anthracis (Anthrax) Infection | Phase 2 | Completed | PharmAthene UK Limited | 415 | 2005-03-01 | 2008-09-15 |
Anthrax (2) · Infections (1) · Plague (1)
United Kingdom (2) · United States (2)
Eric Sheldon, MD (1) · Lawrence Currie, MD (1) · Timothy Mant, MD (1)